Luminal A are characterized by the expression of estrogen receptors (ER) and progesterone receptors (PR) and generally have the best prognosis among different BC types, responding well to the ER antagonist tamoxifen and aromatase inhibitors [6,7]. The gene discussed is PGR; the disease is breast cancer.